18/12/2025
✨ As 2025 draws to a close ✨
This year has been one shaped by courage, collaboration, and a community determined to make things better for everyone affected by neuroendocrine cancer.
Although I am only a few months into my role as CEO, I have been part of Neuroendocrine Cancer UK for some time - and stepping into this role has deepened my appreciation of the strength, generosity and resilience of this community. It is a privilege to work alongside you.
In 2025, together we have:
❤️ Supported almost 3,000 patients and families through our helpline, counselling and support groups
❤️ Expanded webinars, newsletters and online resources to help people feel informed and less alone
❤️ Celebrated our community through the Hero Awards, sharing inspiring stories of courage and compassion
❤️ Strengthened GP education and awareness to support earlier diagnosis
❤️ Put patient voices at the heart of research through the James Lind Alliance Priority Setting Partnership
❤️ Increased investment in research and strengthened our data and policy work to improve outcomes
None of this would be possible without you - patients, families, carers, clinicians, fundraisers, volunteers and supporters. Your voices guide our work, and your generosity drives everything we do.
🎄 Please note: Our office and helpline are now closed, and the team is taking a short break. We’ll be back on Tuesday 6th January and ready to continue supporting our community in the new year.
As we move into 2026, we remain committed to a future of earlier diagnosis, expert care and better outcomes for everyone affected by neuroendocrine cancer.
Lisa, CEO, Neuroendocrine Cancer UK